🧪
hypothesis

ISR/eIF2α~P Overflow Represses Synaptic Proteostasis in Cortical Neurons in TDP-43-Type Frontotemporal Dementia

Hypothesis

ISR/eIF2α~P Overflow Represses Synaptic Proteostasis in Cortical Neurons in TDP-43-Type Frontotemporal Dementia

In ALS, chronic ISR activation creates an eIF2α~P state that represses axonal protein synthesis below synaptic maintenance thresholds, causing NMJ denervation.
🧬 TARDBP (TDP-43)🩺 frontotemporal-dementia🎯 Composite 65%💱 $0.51▲1.9%active↱ Variant of eIF2α Phosphorylation Imbalance Creates Integrated Stress Re
EvidencePending (0%)📖 0 cit🗣 1 debates 3 support 2 oppose
⚠ Missing Evidence⚠ Orphaned Senate Quality Gates →
Mechanistic 0.60 (15%) Evidence 0.65 (15%) Novelty 0.70 (12%) Feasibility 0.00 (12%) Impact 0.00 (12%) Druggability 0.00 (10%) Safety 0.00 (8%) Competition 0.00 (6%) Data Avail. 0.00 (5%) Reproducible 0.00 (5%) KG Connect 0.50 (8%) 0.650 composite
☰ Compare⚛️ Collide
📄 Export LaTeX
arXiv PreprintNeurIPSNature MethodsPLOS ONE
📖 Export BibTeXinteract with this hypothesis
Composite65% · Lineagevariant

🧪 Overview

In ALS, chronic ISR activation creates an eIF2α~P state that represses axonal protein synthesis below synaptic maintenance thresholds, causing NMJ denervation. Analogously, in TDP-43-type FTD, chronic ISR activation driven by TDP-43 aggregates and proteostatic stress may repress local dendritic/synaptic protein synthesis required for glutamatergic synapse stability, contributing to early cortical synaptic loss and frontotemporal network dysfunction. The prediction is that cortical neurons in FTD patients will show elevated eIF2α~P and repressed synaptic proteome expression correlating with cognitive decline.

Analogy rationale: TDP-43 pathology is a shared hallmark of both ALS and FTD (FTD-TDP type B), and both diseases involve proteostatic stress from protein aggregation, providing a plausible mechanistic analog where ISR overflow similarly disrupts local protein synthesis essential for neuronal connectivity.

...

🧬 Mechanism

No curated mechanism pathway recorded for this hypothesis.

⚖️ Evidence

⚖️ Evidence Matrix3 supports2 contradicts
Supports
TDP-43 represses cryptic exon inclusion in the FTD-ALS gene UNC13A.
Nature2022PMID:35197626
Supports
TDP-43 repression of nonconserved cryptic exons is compromised in ALS-FTD.
Science2015PMID:26250685
Supports
A model of human neural networks reveals NPTX2 pathology in ALS and FTLD.
Nature2024PMID:38355792
Contradicts
TDP-43 Pathology in Alzheimer's Disease.
Mol Neurodegener2021PMID:34930382
Contradicts
TDP-43 proteinopathies: a new wave of neurodegenerative diseases.
J Neurol Neurosurg Psychiatry2020PMID:33177049
📖 Linked Papers

No linked papers recorded for this hypothesis yet.

🏥 Translation

🧬 3D Protein Structure — TARDBP

🧬 PDB 4BS2 Click to expand

Experimental structure from RCSB PDB | Powered by Mol*

💉 Clinical Trials

No clinical trials data linked to this hypothesis yet.

No curated ClinVar variants loaded for this hypothesis.

Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.

🔍 Search ClinVar for TARDBP (TDP-43) →

No DepMap CRISPR Chronos data found for TARDBP (TDP-43).

Run python3 scripts/backfill_hypothesis_depmap.py to populate.

🏆 Tournament

🏆 Arenas / Elo

No arena matches recorded yet. Browse Arenas →

📊 Market Indicators

7d Trend
Stable
7d Momentum
▲ 0.0%
Volatility
Low
0.0003
Events (7d)
1
Price History
▲1.9%

💾 Resource Usage

No resource usage or linked notebooks recorded for this hypothesis yet.

View on SciDEX ↗